These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 29624151)

  • 21. Impact of timing of radiation therapy on outcomes in atypical meningioma: A clinical audit.
    Pant S; Tonse R; Kannan S; Moiyadi A; Shetty P; Epari S; Sahay A; Sastri GJ; Jalali R; Gupta T
    Pract Radiat Oncol; 2018; 8(5):e275-e284. PubMed ID: 29861352
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Skull base atypical meningioma: long term surgical outcome and prognostic factors.
    Wang YC; Chuang CC; Wei KC; Hsu YH; Hsu PW; Lee ST; Wu CT; Tseng CK; Wang CC; Chen YL; Jung SM; Chen PY
    Clin Neurol Neurosurg; 2015 Jan; 128():112-6. PubMed ID: 25486076
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Necrosis and Brain Invasion Predict Radio-Resistance and Tumor Recurrence in Atypical Meningioma: A Retrospective Cohort Study.
    Garcia-Segura ME; Erickson AW; Jairath R; Munoz DG; Das S
    Neurosurgery; 2020 Dec; 88(1):E42-E48. PubMed ID: 32818240
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy of radiotherapy and stereotactic radiosurgery as adjuvant or salvage treatment in atypical and anaplastic (WHO grade II and III) meningiomas: a systematic review and meta-analysis.
    Gagliardi F; De Domenico P; Snider S; Pompeo E; Roncelli F; Barzaghi LR; Acerno S; Mortini P
    Neurosurg Rev; 2023 Mar; 46(1):71. PubMed ID: 36928326
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic value of estrogen receptor in WHO Grade III meningioma: a long-term follow-up study from a single institution.
    Hua L; Zhu H; Li J; Tang H; Kuang D; Wang Y; Tang F; Chen X; Zhou L; Xie Q; Gong Y
    J Neurosurg; 2018 Jun; 128(6):1698-1706. PubMed ID: 28820306
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy of adjuvant radiotherapy for atypical and anaplastic meningioma.
    Zhu H; Bi WL; Aizer A; Hua L; Tian M; Den J; Tang H; Chen H; Wang Y; Mao Y; Dunn IF; Xie Q; Gong Y
    Cancer Med; 2019 Jan; 8(1):13-20. PubMed ID: 30680963
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Major complications from radiotherapy following treatment for atypical meningiomas.
    Dawley T; Rana Z; Abou-Al-Shaar H; Goenka A; Schulder M
    Neurosurg Focus; 2019 Jun; 46(6):E5. PubMed ID: 31153147
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Risk factors associated with postoperative recurrence in atypical intracranial meningioma: analysis of 263 cases at a single neurosurgical centre.
    Wang F; Xu D; Liu Y; Lin Y; Wei Q; Gao Q; Lei S; Guo F
    Acta Neurochir (Wien); 2019 Dec; 161(12):2563-2570. PubMed ID: 31641861
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The role of radiotherapy following gross-total resection of atypical meningiomas.
    Komotar RJ; Iorgulescu JB; Raper DM; Holland EC; Beal K; Bilsky MH; Brennan CW; Tabar V; Sherman JH; Yamada Y; Gutin PH
    J Neurosurg; 2012 Oct; 117(4):679-86. PubMed ID: 22920955
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Radiation Therapy for Residual or Recurrent Atypical Meningioma: The Effects of Modality, Timing, and Tumor Pathology on Long-Term Outcomes.
    Sun SQ; Cai C; Murphy RK; DeWees T; Dacey RG; Grubb RL; Rich KM; Zipfel GJ; Dowling JL; Leuthardt EC; Simpson JR; Robinson CG; Chicoine MR; Perrin RJ; Huang J; Kim AH
    Neurosurgery; 2016 Jul; 79(1):23-32. PubMed ID: 26645969
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Benign meningiomas (WHO Grade I) with atypical histological features: correlation of histopathological features with clinical outcomes.
    Marciscano AE; Stemmer-Rachamimov AO; Niemierko A; Larvie M; Curry WT; Barker FG; Martuza RL; McGuone D; Oh KS; Loeffler JS; Shih HA
    J Neurosurg; 2016 Jan; 124(1):106-14. PubMed ID: 26274991
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Survival and Prognostic Predictors of Anaplastic Meningiomas.
    Masalha W; Heiland DH; Delev D; Fennell JT; Franco P; Scheiwe C; Mercas BI; Mader I; Schnell O; Grauvogel J
    World Neurosurg; 2019 Nov; 131():e321-e328. PubMed ID: 31356972
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Glioblastoma in the elderly: the effect of aggressive and modern therapies on survival.
    Babu R; Komisarow JM; Agarwal VJ; Rahimpour S; Iyer A; Britt D; Karikari IO; Grossi PM; Thomas S; Friedman AH; Adamson C
    J Neurosurg; 2016 Apr; 124(4):998-1007. PubMed ID: 26452121
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Survival Benefit of Adjuvant Radiotherapy in Elderly Patients with WHO Grade III Meningioma.
    Zhou H; Bai HX; Chan L; Zhang PJ; Karakousis G; Huang R; Xiao B; Yang L
    World Neurosurg; 2019 Nov; 131():e303-e311. PubMed ID: 31356979
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gross Tumor and Intracranial Control Benefits with Fractionated Radiotherapy Compared with Stereotactic Radiosurgery for Patients with WHO Grade 2 Meningioma.
    Gravbrot N; Rock CB; Weil CR; Rock CB; Burt LM; DeCesaris CM; Jensen RL; Shrieve DC; Cannon DM
    World Neurosurg; 2024 Aug; 188():e259-e266. PubMed ID: 38777319
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Independent association of extent of resection with survival in patients with malignant brain astrocytoma.
    McGirt MJ; Chaichana KL; Gathinji M; Attenello FJ; Than K; Olivi A; Weingart JD; Brem H; Quiñones-Hinojosa AR
    J Neurosurg; 2009 Jan; 110(1):156-62. PubMed ID: 18847342
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Survival and Recurrence Outcomes Following Adjuvant Radiotherapy for Grade 2 Intracranial Meningiomas: 13-Year Experience in a Tertiary-Care Center.
    Rebchuk AD; Alam A; Hounjet CD; Chaharyn BM; Gooderham PA; Yip S; Ma RMK; Nichol A; Makarenko S
    World Neurosurg; 2022 May; 161():e748-e756. PubMed ID: 35240308
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Outcomes following myxopapillary ependymoma resection: the importance of capsule integrity.
    Abdulaziz M; Mallory GW; Bydon M; De la Garza Ramos R; Ellis JA; Laack NN; Marsh WR; Krauss WE; Jallo G; Gokaslan ZL; Clarke MJ
    Neurosurg Focus; 2015 Aug; 39(2):E8. PubMed ID: 26235025
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Should adjuvant radiotherapy be used in atypical meningioma (WHO grade 2) following gross total resection? A systematic review and Meta-analysis.
    Wujanto C; Chan TY; Soon YY; Vellayappan B
    Acta Oncol; 2022 Sep; 61(9):1075-1083. PubMed ID: 36052871
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Extent of resection and survival outcomes in World Health Organization grade II meningiomas.
    Soni P; Davison MA; Shao J; Momin A; Lopez D; Angelov L; Barnett GH; Lee JH; Mohammadi AM; Kshettry VR; Recinos PF
    J Neurooncol; 2021 Jan; 151(2):173-179. PubMed ID: 33205354
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.